Shire PLC (SHP) Stock Rating Reaffirmed by Berenberg Bank
Shire PLC (LON:SHP)‘s stock had its “buy” rating reaffirmed by stock analysts at Berenberg Bank in a research note issued to investors on Wednesday.
Several other analysts have also issued reports on SHP. BNP Paribas reiterated an “outperform” rating and set a GBX 5,900 ($75.43) price objective on shares of Shire PLC in a report on Monday, April 3rd. Barclays PLC reiterated an “overweight” rating and set a GBX 6,500 ($83.10) price objective on shares of Shire PLC in a report on Wednesday, April 12th. Liberum Capital reiterated a “buy” rating and set a GBX 5,500 ($70.31) price objective on shares of Shire PLC in a report on Monday, April 10th. Citigroup Inc reiterated a “buy” rating on shares of Shire PLC in a report on Wednesday, April 12th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a GBX 6,600 ($84.38) price objective on shares of Shire PLC in a report on Friday, February 17th. One investment analyst has rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of GBX 6,115.60 ($78.18).
Shares of Shire PLC (LON:SHP) traded up 1.48% during midday trading on Wednesday, hitting GBX 4564.00. The stock had a trading volume of 2,133,103 shares. The firm has a 50-day moving average price of GBX 4,694.34 and a 200-day moving average price of GBX 4,701.68. Shire PLC has a 1-year low of GBX 2,707.19 and a 1-year high of GBX 5,377.00. The firm’s market cap is GBX 41.20 billion.
The business also recently announced a dividend, which will be paid on Tuesday, April 25th. Shareholders of record on Thursday, March 9th will be issued a dividend of GBX 20.64 ($0.26) per share. This is a positive change from Shire PLC’s previous dividend of $3.51. This represents a yield of 0.43%. The ex-dividend date of this dividend is Thursday, March 9th.
In related news, insider William Burns bought 136 shares of the business’s stock in a transaction on Friday, March 31st. The shares were bought at an average cost of GBX 4,742 ($60.62) per share, for a total transaction of £6,449.12 ($8,244.85).
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.